Xilio Therapeutics, Inc. (XLO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:42 am
Unchanged
2021-12-3113GXILIO THERAPEUTICS INC
XLO
BCLS II Equity Opportunities, LP96,334
4.900%
0
(Unchanged)
Filing
History
2022-02-11
4:14 pm
Sale
2021-12-3113GXILIO THERAPEUTICS INC
XLO
Deerfield Mgmt, L.P.153,861
7.840%
-9,564decrease
(-5.85%)
Filing
History
2022-02-09
10:04 am
Sale
2022-02-0813GXILIO THERAPEUTICS INC
XLO
FMR LLC183,591
9.357%
-6,243decrease
(-3.29%)
Filing
History
2022-01-14
06:07 am
Purchase
2021-12-3113GXILIO THERAPEUTICS INC
XLO
TAKEDA PHARMACEUTICAL CO LTD
TAK
105,366
5.370%
105,366increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2